Brain Scientific Inc.
BRSF · OTC
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -55.6% | -70.3% | -75.9% | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | -127.1% | 64.5% | 1.3% | 33.2% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -2,031% | -35,739.3% | -1,815.4% | -1,067.6% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -77,714.6% | -36,323.8% | -3,173.6% | -1,353.5% |
| EPS Diluted | -3.18 | -3.35 | -1.7 | -3.63 |
| % Growth | 5.1% | -97.1% | 53.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |